Jeena Sikho Lifecare Limited — PPTs, 13-11-2024: Investor Presentation

**Financial Highlights:** Jeena Sikho Lifecare Limited reported a revenue from operations of ₹21,413 lakh for H1FY25, marking a 36% year-over-year increase. Gross profit reached ₹19,236 lakh with a gross margin of approximately 90%. Despite rising operating expenses, EBITDA grew to ₹5,928 lakh, maintaining a margin of 28%. Profit after taxes increased by 47% to ₹4,688 lakh.

**Strategic Initiatives and Growth Drivers:** The company aims to enhance bed utilization, expand its hospital network, and improve operational capacity. There are plans to leverage OTC sales for medicines and explore new product launches. An ambitious pipeline includes adding 20 new facilities, which could significantly increase revenue.

**Business Developments:** The firm operates in over 100 cities and towns across 21 states, with significant patient volume growth in both inpatient and outpatient departments. Recent initiatives have improved operational efficiencies, evidenced by a 20% increase in operational beds.

**Market Position and Competitive Advantage:** Jeena Sikho is positioned as a leading player in the Ayurveda healthcare market, boasting a robust network of NABH accredited facilities and healthy margins across its product portfolios.

**Investor Implications:** Given its strong revenue growth trajectory and ongoing expansion plans, Jeena Sikho presents a positive outlook for potential investors. The strategic focus on operational efficiency and market penetration may bolster long-term shareholder value.